These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 3251456)

  • 41. Effects of COER-verapamil on circadian pattern of forearm vascular resistance and blood pressure.
    Nguyen BN; Parker RB; Noujedehi M; Sullivan JM; Johnson JA
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 2):1480-7. PubMed ID: 11185670
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Calcium metabolism in arterial hypertension. II. Changes in thrombocyte sensitivity to verapamil].
    Atakhanov ShE; Tkhostova EB; Iurenev AP; Men'shikov MIu; Mazaev AV
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1988; 11(1):28-32. PubMed ID: 3401337
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy of sustained-release verapamil: automatic ambulatory blood pressure monitoring.
    Zachariah PK; Sheps SG; Schriger A
    J Clin Hypertens; 1986 Sep; 2(3 Suppl):133S-142S. PubMed ID: 3540223
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serum concentration and antihypertensive effect of slow-release verapamil.
    Schütz E; Ha HR; Bühler FR; Follath F
    J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S346-9. PubMed ID: 6184566
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Comparison of the effect of short-term treatment with nifedipine and verapamil on blood pressure, plasma atrial natriuretic peptide (ANP) and cyclic guanosine monophosphate (cGMP) in patients with primary arterial hypertension I degree according to WHO].
    Widecka K; Marzecka J; Goździk J; Gruszczyńska M; Ciechanowski K; Czekalski S
    Pol Tyg Lek; 1994 Mar 7-14; 49(10-11):228-30. PubMed ID: 7862584
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [A clinical study of the verapamil and captopril combination in hypertensive patients uncontrolled by monotherapy. An evaluation by recording the 24-hour ambulatory blood pressure].
    Mora-Macià J; Ocón Pujadas J; Fernández Vidal P; Garrido García J; Velasco Quintana J; del Río Pérez G
    Med Clin (Barc); 1993 Apr; 100(14):526-30. PubMed ID: 8469038
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effects of nonsteroidal anti-inflammatory drugs on blood pressures of patients with hypertension controlled by verapamil.
    Houston MC; Weir M; Gray J; Ginsberg D; Szeto C; Kaihlenen PM; Sugimoto D; Runde M; Lefkowitz M
    Arch Intern Med; 1995 May; 155(10):1049-54. PubMed ID: 7748048
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Treatment of tachycardiac arrhythmias and arterial hypertension with verapamil].
    Bender F
    Arzneimittelforschung; 1970 Sep; 20():Suppl 9a:1310+. PubMed ID: 4098332
    [No Abstract]   [Full Text] [Related]  

  • 49. Studies with sustained-release verapamil in essential hypertension.
    Silke B
    Br J Clin Pract Suppl; 1988 Apr; 60():53-7. PubMed ID: 3151272
    [No Abstract]   [Full Text] [Related]  

  • 50. [Effect of verapamil in supraventricular extrasystole. Evaluation by dynamic electrocardiography (Holter system)].
    Rocha PJ; Albanesi FM; Albuquerque DC; Benchimol CB; Schlesinger P; Benchimol AB
    Arq Bras Cardiol; 1979 May; 32(5):347-51. PubMed ID: 92982
    [No Abstract]   [Full Text] [Related]  

  • 51. [Acute hypotensive effect after sublingual verapamil].
    Chen YS; Li JL
    Zhonghua Xin Xue Guan Bing Za Zhi; 1989 Feb; 17(1):35-6. PubMed ID: 2766944
    [No Abstract]   [Full Text] [Related]  

  • 52. Mechanisms concerned with blood pressure variability throughout the day.
    Conway J; Boon N; Vann Jones J; Sleight P
    Clin Exp Hypertens A; 1985; 7(2-3):153-7. PubMed ID: 4039990
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immediate effect of intravenous verapamil in hypertension.
    Wasir HS; Kasliwal RR; Bhatia ML
    Indian Heart J; 1979; 31(6):326-9. PubMed ID: 546717
    [No Abstract]   [Full Text] [Related]  

  • 54. [Influence of verapamil in arterial hypertensive syndromes. Preliminary considerations].
    Nicita-Mauro V; Barbera N; Buemi M; Frisina N
    Boll Soc Ital Cardiol; 1978; 23(2):327-32. PubMed ID: 754788
    [No Abstract]   [Full Text] [Related]  

  • 55. [Injectable verapamil as an arterial hypotensive drug--experimental study].
    Mateos DA; Tsuzuki S; Nakiri K; Bittencourt D; Zerbini EJ
    Arq Bras Cardiol; 1977 Jun; 30(3):221-6. PubMed ID: 921571
    [No Abstract]   [Full Text] [Related]  

  • 56. Verapamil in hypertension.
    Tripathy N; Sahoo SK
    Indian Heart J; 1979; 31(6):321-5. PubMed ID: 546716
    [No Abstract]   [Full Text] [Related]  

  • 57. Verapamil, low-sodium regimens, and blood pressure.
    Beard TC; Cooke HM; Gray WR; Wild P
    Lancet; 1986 Nov; 2(8516):1164-5. PubMed ID: 2877315
    [No Abstract]   [Full Text] [Related]  

  • 58. Baroreceptors and hypertension.
    Pickering TG; Sleight P
    Prog Brain Res; 1977; 47():43-60. PubMed ID: 928760
    [No Abstract]   [Full Text] [Related]  

  • 59. Malignant hypertension associated with use of amitriptyline hydrochloride.
    Dunn FG
    South Med J; 1982 Sep; 75(9):1124-5. PubMed ID: 7123337
    [No Abstract]   [Full Text] [Related]  

  • 60. Does prostacyclin sensitize arterial baroreceptors?
    Chapleau MW; Abboud FM
    Am J Physiol; 1992 Feb; 262(2 Pt 2):H621-2. PubMed ID: 1610443
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.